Martek Comments on FDA Announcement of Cardiovascular Qualified Health Claim for DHA
"Martek Comments on FDA Announcement of Cardiovascular Qualified Health Claim for DHA
Thursday September 9, 2:42 pm ET
"COLUMBIA, Md., Sept. 9 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq:MATK - News) commented today on yesterday's FDA announcement allowing conventional foods and dietary supplements containing docosahexaenoic acid (DHA) to make a qualified health claim for reduced risk of coronary heart disease on their product packaging. The claim was, in part, a result of Martek's petition to the FDA in November of 2003. A qualified health claim must be supported by credible scientific evidence. Upon review of this scientific evidence, the FDA concluded that supportive but not conclusive research shows that consumption of DHA and eicosapentaenoic acid (EPA) may reduce the risk of coronary heart disease...."